Supreme Court of California

Reset A A Font size: Print

T.H. v. Novartis Pharmaceuticals Corporation, 233898

Affirming the Court of Appeals determination that the manufacturer of a name brand drug whose labeling directs the warnings provided on its generic bioequivalent's packaging owes a duty of reasonable care to the consumers of the generic drug and that the liability for potential negligence doesn't automatically terminate upon transfer of the company's rights in the name brand drug to a successor manufacturer.

Appellate Information

  • Decided
  • Published 2017/12/21




  • Supreme Court of California


FindLaw Career Center

    Select a Job Title

      Post a Job  |  Careers Home

    View More